Alerts will be sent to your verified email
Verify Email
CHANDAN
|
Chandan Healthcare
|
Jenburkt Pharma
|
Medico Remedies
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.89 % | 18.48 % | 11.79 % |
|
5yr average Equity Multiplier
|
3.38 | 1.2 | 2.18 |
|
5yr Average Asset Turnover Ratio
|
1.41 | 0.95 | 1.48 |
|
5yr Avg Net Profit Margin
|
3.01 % | 16.38 % | 3.76 % |
|
Price to Book
|
0.0 | 3.02 | 8.86 |
|
P/E
|
30.3 | 15.17 | 55.53 |
|
5yr Avg Cash Conversion Cycle
|
-66.59 Days | -16.2 Days | 34.15 Days |
|
Inventory Days
|
23.67 Days | 26.89 Days | 52.67 Days |
|
Days Receivable
|
51.93 Days | 46.84 Days | 107.96 Days |
|
Days Payable
|
184.38 Days | 76.62 Days | 136.18 Days |
|
5yr Average Interest Coverage Ratio
|
4.08 | 75.84 | 9.64 |
|
5yr Avg ROCE
|
19.88 % | 24.52 % | 17.25 % |
|
5yr Avg Operating Profit Margin
|
7.87 % | 20.46 % | 5.84 % |
|
5 yr average Debt to Equity
|
0.83 | 0.03 | 0.3 |
|
5yr CAGR Net Profit
|
n/a | 11.81 % | 38.44 % |
|
5yr Average Return on Assets
|
4.05 % | 15.36 % | 5.66 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.43 % | 46.68 % | 63.79 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.95 % | -9.55 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Chandan Healthcare
|
Jenburkt Pharma
|
Medico Remedies
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|